Literature DB >> 35075247

Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation.

Seungjoon Lee1, Eunsaem Lee2, Sung-Soo Park3, Min Sue Park2, Jaewoo Jung1, Gi June Min3, Silvia Park3, Sung-Eun Lee3, Byung-Sik Cho3, Ki-Seong Eom3, Yoo-Jin Kim3, Seok Lee3, Hee-Je Kim3, Chang-Ki Min3, Seok-Goo Cho3, Jong Wook Lee3, Hyung Ju Hwang4,5, Jae-Ho Yoon6.   

Abstract

Using traditional statistical methods, we previously analyzed the risk factors and treatment outcomes of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after allogeneic hematopoietic cell transplantation. Within the same cohort, we applied machine learning to create prediction and recommendation models. We analyzed 2572 transplants using eXtreme Gradient Boosting (XGBoost) to predict post-transplant VOD/SOS and early death. Using the XGBoost and SHapley Additive exPlanations (SHAP), we found influential factors and devised recommendation models, which were internally verified by repetitive ten-fold cross-validation. SHAP values suggested that gender, busulfan dosage, age, forced expiratory volume, and Disease Risk Index were significant factors for VOD/SOS. The areas under the receiver operating characteristic curves and the areas under the precision-recall curve of the models were 0.740, 0.144 for all VOD/SOS, 0.793, 0.793 for severe to very severe VOD/SOS, and 0.746, 0.304 for early death. According to our single feature recommendation, following the busulfan dosage was the most effective for preventing VOD/SOS. The recommendation method for six adjustable feature sets was also validated, and a subgroup corresponding to five to six features showed significant preventive power for VOD/SOS and early death. Our personalized treatment set recommendation showed reproducibility in repetitive internal validation, but large external cohorts should prospectively validate our model.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35075247     DOI: 10.1038/s41409-022-01583-z

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

1.  Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).

Authors:  Jae-Ho Yoon; Keon Hee Yoo; Ki Woong Sung; Chul Won Jung; Jin Seok Kim; Seung Min Hahn; Hyoung Jin Kang; Je-Hwan Lee; Ho Joon Im; Jae-Sook Ahn; Hoon Kook; Bin Cho; Jong Wook Lee
Journal:  Bone Marrow Transplant       Date:  2019-02-26       Impact factor: 5.483

Review 2.  A survey of neural network-based cancer prediction models from microarray data.

Authors:  Maisa Daoud; Michael Mayo
Journal:  Artif Intell Med       Date:  2019-01-30       Impact factor: 5.326

3.  Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.

Authors:  Yasuyuki Arai; Tadakazu Kondo; Kyoko Fuse; Yasuhiko Shibasaki; Masayoshi Masuko; Junichi Sugita; Takanori Teshima; Naoyuki Uchida; Takahiro Fukuda; Kazuhiko Kakihana; Yukiyasu Ozawa; Tetsuya Eto; Masatsugu Tanaka; Kazuhiro Ikegame; Takehiko Mori; Koji Iwato; Tatsuo Ichinohe; Yoshinobu Kanda; Yoshiko Atsuta
Journal:  Blood Adv       Date:  2019-11-26

4.  Machine learning in predicting graft failure following kidney transplantation: A systematic review of published predictive models.

Authors:  Sameera Senanayake; Nicole White; Nicholas Graves; Helen Healy; Keshwar Baboolal; Sanjeewa Kularatna
Journal:  Int J Med Inform       Date:  2019-08-24       Impact factor: 4.046

5.  Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.

Authors:  Christopher Strouse; Ying Zhang; Mei-Jie Zhang; Alyssa DiGilio; Marcelo Pasquini; Mary M Horowitz; Stephanie Lee; Vincent Ho; Muthalagu Ramanathan; Wichai Chinratanalab; Alison Loren; Linda J Burns; Andrew Artz; Kathleen F Villa; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-19       Impact factor: 5.742

6.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Brent R Logan; Zhiwei Wang; Edwin P Alyea; Matt E Kalaycio; Richard T Maziarz; Joseph H Antin; Robert J Soiffer; Daniel J Weisdorf; J Douglas Rizzo; Mary M Horowitz; Wael Saber
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

7.  Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study.

Authors:  Roni Shouval; Myriam Labopin; Ori Bondi; Hila Mishan-Shamay; Avichai Shimoni; Fabio Ciceri; Jordi Esteve; Sebastian Giebel; Norbert C Gorin; Christoph Schmid; Emmanuelle Polge; Mahmoud Aljurf; Nicolaus Kroger; Charles Craddock; Andrea Bacigalupo; Jan J Cornelissen; Frederic Baron; Ron Unger; Arnon Nagler; Mohamad Mohty
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

8.  Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies.

Authors:  Jocelyn S Gandelman; Michael T Byrne; Akshitkumar M Mistry; Hannah G Polikowsky; Kirsten E Diggins; Heidi Chen; Stephanie J Lee; Mukta Arora; Corey Cutler; Mary Flowers; Joseph Pidala; Jonathan M Irish; Madan H Jagasia
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

9.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Authors:  M Mohty; F Malard; M Abecassis; E Aerts; A S Alaskar; M Aljurf; M Arat; P Bader; F Baron; A Bazarbachi; D Blaise; F Ciceri; S Corbacioglu; J-H Dalle; F Dignan; T Fukuda; A Huynh; T Masszi; M Michallet; A Nagler; M NiChonghaile; S Okamoto; A Pagliuca; C Peters; F B Petersen; P G Richardson; T Ruutu; B N Savani; E Wallhult; I Yakoub-Agha; R F Duarte; E Carreras
Journal:  Bone Marrow Transplant       Date:  2016-05-16       Impact factor: 5.483

10.  Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.

Authors:  Catherine Lee; Sebastien Haneuse; Hai-Lin Wang; Sherri Rose; Stephen R Spellman; Michael Verneris; Katharine C Hsu; Katharina Fleischhauer; Stephanie J Lee; Reza Abdi
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.